MORGAN STANLEY - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$580,000
+187.1%
125,832
+118.3%
0.00%
Q4 2018$202,000
-70.6%
57,644
-15.5%
0.00%
Q3 2018$688,000
+14.5%
68,244
-17.8%
0.00%
Q2 2018$601,000
+32.1%
82,996
+10.1%
0.00%
Q1 2018$455,000
-48.8%
75,406
-18.3%
0.00%
Q4 2017$888,000
-44.7%
92,250
-49.0%
0.00%
Q3 2017$1,607,000
-7.1%
180,907
+32.2%
0.00%
-100.0%
Q2 2017$1,730,000
-38.7%
136,792
-49.1%
0.00%
Q1 2017$2,824,000
+7.4%
268,752
-6.0%
0.00%
Q4 2016$2,630,000
+42.2%
285,948
+82.3%
0.00%
-100.0%
Q3 2016$1,850,000
+18.4%
156,892
+29.9%
0.00%0.0%
Q2 2016$1,562,000
-47.3%
120,736
-34.9%
0.00%0.0%
Q1 2016$2,962,000
-27.8%
185,328
+29.3%
0.00%0.0%
Q4 2015$4,105,000
-21.5%
143,386
-22.0%
0.00%
-50.0%
Q3 2015$5,232,000
+165.2%
183,781
+234.7%
0.00%
+100.0%
Q2 2015$1,973,000
-57.9%
54,910
-31.8%
0.00%
-50.0%
Q1 2015$4,681,000
-59.9%
80,524
-70.9%
0.00%
-50.0%
Q4 2014$11,660,000
+533.7%
276,574
+482.8%
0.00%
+300.0%
Q3 2014$1,840,000
-63.1%
47,460
-70.2%
0.00%
-50.0%
Q2 2014$4,980,000
-42.1%
159,460
-23.2%
0.00%
-50.0%
Q1 2014$8,599,000
+9.5%
207,522
+2.3%
0.00%
+33.3%
Q4 2013$7,851,000
+53.8%
202,808
+39.0%
0.00%
+50.0%
Q3 2013$5,104,000
+2199.1%
145,871
+808.3%
0.00%
Q2 2013$222,00016,0590.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders